Atara Biotherapeutics (STU:AT2) Current Deferred Revenue : €113.30 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Atara Biotherapeutics Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Atara Biotherapeutics's current deferred revenue for the quarter that ended in Mar. 2024 was €113.30 Mil.

Atara Biotherapeutics Current Deferred Revenue Historical Data

The historical data trend for Atara Biotherapeutics's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atara Biotherapeutics Current Deferred Revenue Chart

Atara Biotherapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Deferred Revenue

Get a 7-Day Free Trial

27.50

36.07

7.55

71.37

Atara Biotherapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Deferred Revenue	Get a 7-Day Free Trial															9.27	11.03	10.88	71.37	113.30

Atara Biotherapeutics Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Atara Biotherapeutics's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Atara Biotherapeutics (STU:AT2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atara Biotherapeutics Inc (STU:AT2) » Definitions » Current Deferred Revenue

Comparable Companies

Traded in Other Exchanges

ATRA:USA AT2:Germany

Address

2380 Conejo Spectrum St, Suite 200, Thousand Oaks, CA, USA, 91320

Website

https://www.atarabio.com

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Atara Biotherapeutics (STU:AT2) Headlines

No Headlines